Literature DB >> 6192229

Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology.

K Tomiwa, H Mikawa, F Hazama, K Yazawa, R Hosoya, T Ohya, K Nishimura.   

Abstract

The syndrome of inappropriate secretion of antidiuretic hormone is a rare but well-recognized neurotoxic side effect of vincristine therapy. The first neuropathological report of a case is presented. A 6-month-old boy with skin leukemia developed inappropriate secretion of antidiuretic hormone caused by vincristine. Postmortem examination revealed axonal spheroids in the ansa lenticularis and the area surrounded by the substantia innominata, amygdala and supraoptic nucleus. The lesion was confined to that area and the neurosecretory neurons were intact with well preserved neurophysin. The pathological findings suggest that these fibers play a role in the development of inappropriate secretion of antidiuretic hormone caused by vincristine therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192229     DOI: 10.1007/bf00313556

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  HYPONATREMIA AND THE INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE.

Authors:  M GOLDBERG
Journal:  Am J Med       Date:  1963-09       Impact factor: 4.965

2.  A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone.

Authors:  W B SCHWARTZ; W BENNETT; S CURELOP; F C BARTTER
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

Review 3.  Vincristine neurotoxicity.

Authors:  S Rosenthal; S Kaufman
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

4.  Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy.

Authors:  H O Cutting
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

5.  Neurofibrillary degeneration induced by vincristine therapy.

Authors:  M L Shelanski; H Wiśniewski
Journal:  Arch Neurol       Date:  1969-02

6.  Reactive neuroaxonal dystrophy in children. Clinical pathological correlation.

Authors:  H Mei Liu
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

7.  Axonal transport disturbances in vincristine-induced peripheral neuropathy.

Authors:  L S Green; J A Donoso; I E Heller-Bettinger; F E Samson
Journal:  Ann Neurol       Date:  1977-03       Impact factor: 10.422

8.  Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier.

Authors:  K Tomiwa; F Hazama; H Mikawa
Journal:  Neuropathol Appl Neurobiol       Date:  1983 Sep-Oct       Impact factor: 8.090

9.  Axonal dystrophy in the gracile nucleus in children and young adults. Reappraisal of the incidence and associated diseases.

Authors:  J H Sung; A R Mastri; S H Park
Journal:  J Neuropathol Exp Neurol       Date:  1981-01       Impact factor: 3.685

10.  Fatal myeloencephalopathy caused by intrathecal vincristine.

Authors:  H Slyter; B Liwnicz; M K Herrick; R Mason
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

View more
  3 in total

Review 1.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

2.  Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.

Authors:  Marie Lindhard Madsen; Hanne Due; Niels Ejskjær; Paw Jensen; Jakob Madsen; Karen Dybkær
Journal:  Cancer Chemother Pharmacol       Date:  2019-06-18       Impact factor: 3.333

3.  Hyponatremia During Induction Therapy in Distinct Pediatric Oncological Cohorts: A Retrospective Study.

Authors:  Christina Salvador; Robert Salvador; Peter Willeit; Christine Kuntner; Alexandra Haid; Thomas Müller; Gabriele Kropshofer; Roman Crazzolara
Journal:  Front Oncol       Date:  2021-10-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.